Enter your terms above and click the 'Search' button.

Showing articles 0 to 10 of 10 Filter Applied: immune-related adverse events (Click to remove) Confused About Confusion NEJM 386:80-87, Spanjaart, A.M.,et al, 2022 Pembrolizumab-Induced Migrating Cortico-Subcortical Brain Lesions Ann Neurol 89:1255-1256, Lambert, N.,et al, 2021 Autoimmune Encephalitis Related to Cancer Treatment with Immune Checkpoint Inhibitors Neurol 97:e191-e202, Nersesjan, V.,et al, 2021 Drug-Related Demyelinating Syndromes: Understanding Risk Factors, Pathophysiological Mechanisms and Magnetic Resonance Imaging Findings Mult Scler Rel Dis 55:103146, Rimkus, C.M.,et al, 2021 Severe Neurological Toxicity of Immune Checkpoint Inhibitors: Growing Spectrum Ann Neurol 87:659-669, Dubey, D.,et al, 2020 Acute demyelinating polyneuropathy induced by nivolumab JNNP 89:435-437, Fukumoto, Y.,et al, 2018 Autoimmune Pancerebellitis Associated with Pembrolizumab Therapy Neurol 91:91-93, Vitt, J.R.,et al, 2018 Nivolumab-Induced Autoimmune Encephalitis in Two Patients with Lung Adenocarcinoma Case Rep Neurol Med 2018;doi:10.1155/2018/2548528, Shah, S.,et al, 2018 Progressive Multifocal Leukoencephalopathy after Treatment with Nivolumab Emerg Inf Dis 24:1594-1596, Martinot, M.,et al, 2018 Neurological Immune-Related Adverse Events of Ipilimumab Pract Neurol 13:278-280, Bot, I.,et al, 2013 Showing articles 0 to 10 of 10